PMID- 34226528 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210724 IS - 2058-7716 (Print) IS - 2058-7716 (Electronic) IS - 2058-7716 (Linking) VI - 7 IP - 1 DP - 2021 Jun 29 TI - Endothelial-specific insulin receptor substrate-1 overexpression worsens neonatal hypoxic-ischemic brain injury via mTOR-mediated tight junction disassembly. PG - 150 LID - 10.1038/s41420-021-00548-3 [doi] LID - 150 AB - Hypoxic-ischemic (HI) encephalopathy is the major cause of mortality and disability in newborns. The neurovascular unit is a major target of acute and chronic brain injury, and therapies that protect simultaneously both neurons and vascular endothelial cells from neonatal HI injury are in demand. Insulin receptors and its key downstream molecule-insulin receptor substrate -1 (IRS-1) are potential neuroprotective targets and expressed both in neuron and endothelial cells. To investigate whether IRS-1 can act similarly in neurons and vascular endothelial cells in protecting neurovascular units and brain form HI injury, we found that neuron-specific IRS-1 transgenic rats showed reduced neurovascular injury and infarct volumes, whereas endothelial-specific IRS-1 transgenic rats showed increased blood-brain barrier (BBB) disruption and exaggerated neurovascular injury after neonatal HI brain injury. Endothelial-specific IRS-1 overexpression increased vascular permeability and disassembled the tight junction protein (zonula occludens-1) complex. Inhibition of mammalian target of rapamycin (mTOR) by rapamycin preserved tight junction proteins and attenuated BBB leakage and neuronal apoptosis after HI in the endothelial-specific IRS-1 transgenic pups. Together, our findings suggested that neuronal and endothelial IRS-1 had opposite effects on the neurovascular integrity and damage after neonatal HI brain injury and that endothelial IRS-1 worsens neurovascular integrity after HI via mTOR-mediated tight junction protein disassembly. FAU - Tu, Yi-Fang AU - Tu YF AUID- ORCID: 0000-0002-9498-6178 AD - Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. nckutu@gmail.com. AD - Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. nckutu@gmail.com. FAU - Jiang, Si-Tse AU - Jiang ST AD - National Laboratory Animal Center, National Applied Research Laboratories, Taipei, Taiwan. FAU - Chiang, Chi-Wu AU - Chiang CW AD - Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. FAU - Chen, Li-Ching AU - Chen LC AD - TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan. FAU - Huang, Chao-Ching AU - Huang CC AD - Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. LA - eng GR - NCKUH-10105002/National Cheng Kung University Hospital (NCKU Hospital)/ PT - Journal Article DEP - 20210629 PL - United States TA - Cell Death Discov JT - Cell death discovery JID - 101665035 PMC - PMC8257791 COIS- The authors declare no competing interests. EDAT- 2021/07/07 06:00 MHDA- 2021/07/07 06:01 PMCR- 2021/06/29 CRDT- 2021/07/06 05:59 PHST- 2021/02/12 00:00 [received] PHST- 2021/06/09 00:00 [accepted] PHST- 2021/05/09 00:00 [revised] PHST- 2021/07/06 05:59 [entrez] PHST- 2021/07/07 06:00 [pubmed] PHST- 2021/07/07 06:01 [medline] PHST- 2021/06/29 00:00 [pmc-release] AID - 10.1038/s41420-021-00548-3 [pii] AID - 548 [pii] AID - 10.1038/s41420-021-00548-3 [doi] PST - epublish SO - Cell Death Discov. 2021 Jun 29;7(1):150. doi: 10.1038/s41420-021-00548-3.